TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
COVID-19 in pregnancy
Key Statistics
- 2.64/100,000 — UK COVID-19 case fatality rate, per maternities
- 83% — mRNA vaccine effectiveness vs hospitalisation
- 94–98% — Target oxygen saturations (RCOG)
Don't-miss facts
-
Escalate: oxygen requirement, RR ≥20/min or HR ≥110 bpm → urgent MDT (RCOG). Target sats 94–98%
-
Urgent critical care review: RR ≥25 despite O₂, FiO₂ >35%, ↓urine output, creatinine >77 µmol/L, altered mentation
-
Antenatal steroid = unfluorinated (prednisolone/methylprednisolone/hydrocortisone; ~10% reaches fetus). Dexamethasone only if preterm delivery imminent
-
Sotrovimab within 5 days of symptom onset (RRR 85%); tocilizumab/sarilumab if hypoxic; remdesivir by MDT decision if deteriorating
-
Give prophylactic LMWH to all pregnant women admitted or severely ill with COVID-19
-
Prone up to at least 28 weeks; beyond that use left lateral decubitus (WHO/RCOG)
-
Pregnancy is not a contraindication to ECMO – refer early if deteriorating (maternal survival 77.2%)
-
Only mRNA vaccines licensed in UK pregnancy; effectiveness 83%; ideally >9 days before birth for neonatal antibody transfer. Breastfeeding recommended
Key outcome odds ratios (Allotey et al.)
ICU admission OR 2.61 Invasive ventilation OR 2.41 Death OR 6.09 Preterm birth OR 1.57 Caesarean OR 1.17
Stillbirth OR 1.81 Neonatal death OR 2.35 No ↑ miscarriage <24 weeks Vertical transmission 0.9–2.8%
Abbreviation Key
- ACE-2 — angiotensin-converting enzyme 2
- ASC — antibody-secreting cell
- TMPRSS2 — transmembrane serine protease 2
- NP — nucleocapsid protein
- RAS/RAA — renin–angiotensin–aldosterone system
- LMIC — low- and middle-income country
- VoC — variant of concern
- LMWH — low molecular weight heparin
- MBRRACE — Mothers and Babies: Reducing Risk through Audits
- UKTIS — UK Teratology Information Service and Confidential Enquiries
- FGR — fetal growth restriction
- ECMO — extracorporeal membrane oxygenation
- FiO₂/PaO₂ — inspired O₂ fraction / arterial O₂ pressure
- cTFH — circulating T follicular helper cells
Source: Greer O, Saeed Z, Woon EV et al. COVID-19 in pregnancy. The Obstetrician & Gynaecologist 2025;27:43–56. doi:10.1111/tog.12960
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).